Immunosurveillance and therapy of multiple myeloma are CD226 dependent.
Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, Teng MW, Colonna M, Ritchie DS, Chesi M, Bergsagel PL, Hill GR, Smyth MJ, Martinet L.
Guillerey C, et al.
J Clin Invest. 2015 Jul 1;125(7):2904. doi: 10.1172/JCI82646. Epub 2015 Jun 15.
J Clin Invest. 2015.
PMID: 26075821
Free PMC article.
No abstract available.